STOCK TITAN

Select Medical Holdings Corporation Announces Declaration of a Special Stock Distribution to Spin-Off Concentra

Rhea-AI Impact
(Moderate)
Rhea-AI Sentiment
(Neutral)
Tags

Select Medical Holdings has announced a special stock distribution of its Concentra holdings to shareholders. The distribution will occur on November 25, 2024, with a record date of November 18, 2024. Stockholders will receive approximately 0.806971 shares of Concentra's common stock (NYSE: CON) for each share of Select Medical stock held. The distribution represents about 81.7% of Concentra's outstanding shares, totaling 104,093,503 shares. The transaction is intended to be tax-free for U.S. federal income tax purposes, and no stockholder action is required. Cash will be provided in lieu of fractional shares.

Select Medical Holdings ha annunciato una distribuzione speciale di azioni delle sue partecipazioni in Concentra ai suoi azionisti. La distribuzione avrà luogo il 25 novembre 2024, con una data di registrazione fissata al 18 novembre 2024. Gli azionisti riceveranno circa 0,806971 azioni ordinarie di Concentra (NYSE: CON) per ogni azione di Select Medical posseduta. La distribuzione rappresenta circa l'81,7% delle azioni in circolazione di Concentra, per un totale di 104.093.503 azioni. La transazione è progettata per essere esente da tasse per fini fiscali federali negli Stati Uniti, e non è richiesta alcuna azione da parte degli azionisti. In caso di azioni frazionarie, verrà fornito un pagamento in contante.

Select Medical Holdings ha anunciado una distribución especial de acciones de sus participaciones en Concentra a los accionistas. La distribución se llevará a cabo el 25 de noviembre de 2024, con una fecha de corte el 18 de noviembre de 2024. Los accionistas recibirán aproximadamente 0,806971 acciones ordinarias de Concentra (NYSE: CON) por cada acción de Select Medical que posean. La distribución representa aproximadamente el 81,7% de las acciones en circulación de Concentra, sumando un total de 104.093.503 acciones. La transacción está destinada a ser libre de impuestos para fines del impuesto federal sobre la renta en EE. UU., y no se requiere ninguna acción por parte de los accionistas. Se proporcionará efectivo en lugar de acciones fraccionarias.

Select Medical Holdings는 주주들에게 Concentra 보유 주식의 특별 배당을 발표했습니다. 배당은 2024년 11월 25일에 진행되며, 기록 날짜는 2024년 11월 18일입니다. 주주들은 Select Medical 주식 1주당 약 0.806971주(뉴욕증권거래소: CON)의 Concentra 보통주를 받게 됩니다. 이 배당은 Concentra의 유통 주식의 약 81.7%를 차지하며, 총 104,093,503주의 주식이 포함됩니다. 이 거래는 미국 연방 소득세 목적상 세금 면제가 될 예정이며, 주주의 별도 조치는 필요하지 않습니다. 분할 주식의 경우 현금으로 지급됩니다.

Select Medical Holdings a annoncé une distribution spéciale d'actions de ses participations dans Concentra aux actionnaires. La distribution aura lieu le 25 novembre 2024, avec une date de référence au 18 novembre 2024. Les actionnaires recevront environ 0,806971 actions ordinaires de Concentra (NYSE : CON) pour chaque action de Select Medical détenue. La distribution représente environ 81,7 % des actions en circulation de Concentra, totalisant 104 093 503 actions. La transaction est destinée à être exonérée d'impôt pour les besoins de l'impôt fédéral sur le revenu américain, et aucune action de la part des actionnaires n'est requise. Un paiement en espèces sera fourni en lieu et place des actions fractionnaires.

Select Medical Holdings hat eine spezielle Aktienverteilung seiner Bestände an Concentra an die Aktionäre angekündigt. Die Verteilung wird am 25. November 2024 stattfinden, mit einem Stichtag am 18. November 2024. Aktionäre erhalten für jede gehaltene Aktie von Select Medical etwa 0,806971 Stammaktien von Concentra (NYSE: CON). Die Verteilung entspricht etwa 81,7 % der ausstehenden Aktien von Concentra, insgesamt 104.093.503 Aktien. Die Transaktion ist für die Zwecke der US-Bundes-Einkommensteuer steuerfrei, und es ist keine Aktion seitens der Aktionäre erforderlich. Bargeld wird im Austausch für Bruchstücke von Aktien bereitgestellt.

Positive
  • Tax-free distribution to shareholders
  • Distribution of 81.7% ownership in Concentra to shareholders
  • No action required from stockholders
Negative
  • Divestment of majority stake in profitable Concentra segment
  • Reduction in Select Medical's business diversification

Insights

This spin-off transaction represents a significant strategic move that will reshape both Select Medical and Concentra. The distribution of 81.7% of Concentra's shares to Select Medical stockholders, at an approximate ratio of 0.806971 Concentra shares per Select Medical share, will create two distinct publicly traded companies.

The tax-free nature of the distribution enhances shareholder value by avoiding immediate tax implications. The involvement of major financial institutions like J.P. Morgan and Goldman Sachs adds credibility to the transaction. Post-spin-off, shareholders will maintain exposure to both the broader healthcare services through Select Medical and the specialized occupational health sector through Concentra, allowing for more focused investment strategies and potentially better market valuations for each entity.

The complex trading arrangements between November 20-25 provide flexibility for investors to manage their positions, though careful attention should be paid to the different trading markets ("regular way," "ex-distribution," and "when-issued") to avoid unintended consequences.

This separation creates a pure-play opportunity in the occupational health services sector through Concentra, which operates 549 occupational health centers and 156 onsite health clinics across 45 states. The spin-off allows Concentra to pursue its growth strategy independently while maintaining its position as the largest U.S. occupational health services provider.

Select Medical will retain its focus on critical illness recovery hospitals, rehabilitation facilities and outpatient clinics. With 106 critical illness recovery hospitals, 34 rehabilitation hospitals and 1,925 outpatient rehabilitation clinics, the company remains a significant player in specialized healthcare services. This strategic separation should enable both companies to optimize their respective business models and capital allocation strategies.

MECHANICSBURG, Pa., Nov. 6, 2024 /PRNewswire/ -- Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE: SEM) today announced that its Board of Directors has approved a special stock distribution (the "Distribution") to Select Medical's stockholders of the 104,093,503 shares of common stock of Concentra Group Holdings Parent, Inc. ("Concentra") (NYSE: CON) owned by Select Medical Corporation ("SMC"), a wholly owned subsidiary of Select Medical, representing approximately 81.7% of the outstanding shares of Concentra's common stock.

The Distribution by Select Medical of the special stock distribution will be made on November 25, 2024 (the "Distribution Date") to all of Select Medical's stockholders on the record date of November 18, 2024 (the "Record Date"). The Distribution will consist of a pro rata common stock distribution to each of Select Medical's stockholders on the Record Date. As of November 5, 2024, Select Medical had approximately 128,992,850 shares of its common stock, par value $0.001 per share, outstanding. Based on such number, Select Medical estimates that Select Medical's stockholders will receive approximately 0.806971 shares of Concentra's common stock for every share of Select Medical's common stock held as of the close of business on the Record Date. The final distribution ratio will be determined based on the number of shares of Select Medical's common stock outstanding on the Record Date.

No fractional shares of Concentra's common stock will be distributed. Instead, Select Medical's stockholders will receive cash in lieu of any fraction of a share of Concentra's common stock that they otherwise would have received. The Distribution is generally intended to qualify as tax free to Select Medical's stockholders for U.S. federal income tax purposes.

J.P. Morgan and Goldman Sachs are acting as financial advisors to Select Medical in connection with the Distribution. Dechert LLP is acting as legal advisor to Select Medical in connection with the Distribution.

Information Regarding the Spin-off Transaction

No vote or action is required by Select Medical's stockholders in order to receive the Distribution of shares of Concentra's common stock.

Select Medical's stockholders on the Record Date will receive account statements reflecting their ownership interest in shares of Concentra's common stock. Concentra's common stock issued in the Distribution will be in book-entry form. Select Medical's stockholders who hold their shares through brokers or other nominees will have their shares of Concentra's common stock credited to their accounts by their nominees or brokers. Select Medical's stockholders will not be required to pay cash or other consideration for the shares of Concentra's common stock to be distributed to them, or surrender or exchange their shares of Select Medical's common stock to receive the Distribution.

Select Medical plans to make available an information statement regarding this transaction to its stockholders of record on the Record Date on or about November 19, 2024. The information statement will include details on the Distribution and also will be posted on Select Medical's website at https://www.selectmedical.com/investor-relations/.

Trading in Shares of Select Medical and Concentra Common Stock Between Record Date and Distribution Date

  • Select Medical's common stock "regular way" market (NYSE: SEM): Shares of Select Medical's common stock that trade in the "regular way" market will trade with "due bills," which are entitlements to shares of Concentra's common stock to be distributed in the Distribution. Any holders of shares of Select Medical's common stock who sell Select Medical's shares outstanding as of the Record Date the "regular way" on or prior to the Distribution Date will also be selling their right to receive the shares of Concentra's common stock that were to be distributed to them in respect of those shares of Select Medical's common stock.

  • Concentra's common stock "regular way" market (NYSE: CON): The "regular way" market is the same market for Concentra's common stock that has been in existence since Concentra completed its initial public offering of its common stock in July 2024.

Beginning on November 20, 2024, the date which is three (3) trading days prior to the Distribution Date, and continuing through the close of trading on the Distribution Date, the following markets will exist in shares of Select Medical's and Concentra's common stock, in addition to Select Medical's common stock "regular way" market:

  • Select Medical's common stock "ex-distribution/when-issued" market (NYSE: SEM WI): Shares of Select Medical's common stock that trade in the "ex-distribution/when-issued" market will trade without an entitlement to shares of Concentra's common stock to be distributed in the Distribution. If you own shares of Select Medical's common stock on the Record Date and sell those shares of Select Medical's common stock in the "ex-distribution/when-issued" market prior to or on the Distribution Date, you will still receive the shares of Concentra's common stock that were to be distributed to you in respect of those shares of Select Medical's common stock.

  • Concentra's common stock "when-issued" market (NYSE: CON WI): The "when-issued" market for Concentra's common stock relates to the shares of Concentra's common stock that will be distributed to Select Medical's stockholders in the Distribution. Therefore, if you are entitled to receive shares of Concentra's common stock in the Distribution, you may trade your entitlement to such shares of Concentra's common stock, without the corresponding shares of Select Medical's common stock you own, in Concentra's common stock "when-issued" market.

All trades in the "regular way" markets will settle on the trading day after the trade date. The "due bills" will settle on the trading day after the Distribution Date. All trades in the "ex-distribution/when-issued" market and "when-issued" markets will settle on the second trading day after the Distribution Date, irrespective of the trade date.

Concentra's common stock currently trades on the NYSE under the symbol "CON."

You are encouraged to consult with your financial advisor regarding the specific implications of trading Select Medical's common stock and Concentra's common stock prior to or on the Distribution Date.

About Select Medical

Select Medical is one of the largest operators of critical illness recovery hospitals, rehabilitation hospitals, outpatient rehabilitation clinics, and occupational health centers in the United States based on number of facilities.  Select Medical's reportable segments include the critical illness recovery hospital segment, the rehabilitation hospital segment, the outpatient rehabilitation segment, and the Concentra segment. As of September 30, 2024, Select Medical operated 106 critical illness recovery hospitals in 29 states, 34 rehabilitation hospitals in 13 states, 1,925 outpatient rehabilitation clinics in 39 states and the District of Columbia, and 549 occupational health centers in 41 states. At September 30, 2024, Select Medical had operations in 46 states and the District of Columbia. Information about Select Medical is available at www.selectmedical.com.

About Concentra

Concentra is the largest provider of occupational health services in the United States by number of locations, with the mission of improving the health of America's workforce, one patient at a time. Concentra's 11,000 colleagues and affiliated physicians and clinicians support the delivery of an extensive suite of services, including occupational and consumer health services and other direct-to-employer care, to more than 50,000 patients each day on average across 45 states at its 549 occupational health centers, 156 onsite health clinics at employer worksites, and Concentra Telemed as of September 30, 2024.

This press release may contain forward-looking statements based on current management expectations. Numerous factors, including those related to market conditions and those detailed from time-to-time in Select Medical's filings with the Securities and Exchange Commission, may cause results to differ materially from those anticipated in the forward-looking statements. Many of the factors that will determine Select Medical's future results are beyond the ability of Select Medical to control or predict. These statements are subject to risks and uncertainties and, therefore, actual results may differ materially. Readers should not place undue reliance on forward-looking statements, which reflect management's views only as of the date hereof. Select Medical undertakes no obligation to revise or update any forward-looking statements, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.

Investor inquiries:

Joel T. Veit
Senior Vice President and Treasurer
717-972-1100
ir@selectmedical.com

Cision View original content:https://www.prnewswire.com/news-releases/select-medical-holdings-corporation-announces-declaration-of-a-special-stock-distribution-to-spin-off-concentra-302297993.html

SOURCE - Select Medical Holdings Corporation

FAQ

What is the distribution ratio for Select Medical's Concentra stock spin-off?

Stockholders will receive approximately 0.806971 shares of Concentra (CON) for each share of Select Medical stock held as of November 18, 2024.

When will Select Medical distribute Concentra (CON) shares to stockholders?

The distribution will occur on November 25, 2024, to stockholders of record as of November 18, 2024.

How many Concentra (CON) shares will Select Medical distribute in the spin-off?

Select Medical will distribute 104,093,503 shares of Concentra common stock, representing approximately 81.7% of Concentra's outstanding shares.

Is the Concentra (CON) stock distribution taxable for shareholders?

The distribution is generally intended to qualify as tax-free to Select Medical's stockholders for U.S. federal income tax purposes.

Concentra Group Holdings Parent, Inc.

NYSE:CON

CON Rankings

CON Latest News

CON Stock Data

2.51B
22.50M
11.63%
21.42%
1.59%
Medical Care Facilities
Services-specialty Outpatient Facilities, Nec
Link
United States of America
MECHANICSBURG